Patent ID: 9652595
Date: 2017-05-16
CPC Classifications: G16H,G16Z

Claim:
1. A kit for individualized intravenous exogenous insulin-based therapy to improve cellular ATP function comprising: a. a blood glucose meter for measuring metabolic factors of a subject forming measured metabolic factors; b. an intravenous catheter to deliver a plurality of insulin bolus volume dosage amounts sequentially using an individualized schedule with at least one unequal time period between at least one pair of insulin bolus volume dosage amounts; c. an administrative processor configured to create a subject profile comprising: d. a diabetic treatment model; e. a Library of Care Plan templates configured to produce a populated care plan for each subject profile and setting a plan goal using the diabetic treatment model and the care plan generating a customized schedule for each insulin bolus volume dosage amount and an amount of glucose to be consumed by a subject; f. a glucose dosage amount to stimulate a gastrointestinal hormone production in the subject resulting in a release of enzymes from a liver and causing blood glucose levels of the subject to be in a therapeutic range; g. the administrative processor configured to: wherein the portable data storage is configured to instruct the administrative processor to change a weight management protocol and a care plan after a first treatment session to manage weight of the subject using at least one of a plurality of metabolic enhancements to cause improved cellular ATP functioning for the subject while infusing the plurality of insulin bolus volume dosage amounts and modifying a quantity and a duration of unequal time periods between the insulin bolus volume dosage amounts in the generated individualized schedule to improve impaired hepatic glucose processing.